布比卡因脂质体术后镇痛应用进展

Abstract
Figure/Table
References
Related Citation (15)

[1]	马培奇. 美FDA批准布比卡因脂质体注射用悬浮液Exparel治疗术后疼痛 [J]. 上海医药,2012,33(15): 29.
[2]	Hu B, Lin T, Yan S G, et al. Local infiltration analgesia versus regional blockade for postoperative analgesia in total knee arthroplasty: a meta-analysis of randomized controlled trials [J]. Pain Physician, 2016, 19(4): 205-214.
[3]	刘岳峰,胡建华,刘红辉,等. 基于循证药学评价关节周围注射布比卡因脂质体对全膝关节置换术后疼痛和膝关节功能恢复的效果[J]. 临床医药实践,2021, 30(4): 252-258.
[4]	Meyer L A, Corzo C, Iniesta M D, et al. A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway [J]. Am J Obstet Gynecol, 2021, 224(1): 70.e1-70.e11.
[5]	Subramaniam K, Sciortino C M, Boisen M L, et al. Sternotomy wound infiltration with liposomal versus plain bupivacaine for postoperative analgesia after elective cardiac surgery [J]. J Cardiothorac Vasc Anesth, 2023, 37(1): 42-49.
[6]	Vanwagner M J, Krebs N M, Corser W, et al. Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty [J]. Hip Int, 2019, 29(3): 276-281.
[7]	Rainville E C, Asche C, Ren J, et al. Evaluation of intraoperative, local site injections of liposomal bupivacaine as an alternative to standard local anesthetics in patients undergoing total hip arthroplasty [J]. Hosp Pharm, 2020, 55(4): 273-278.
[8]	Kendall M C, Castro L J, Oliveira G R. Liposome bupivacaine compared to plain local anesthetics to reduce postsurgical pain: an updated meta-analysis of randomized controlled trials [J]. Pain Res Treat, 2018, 2018: 5710169.
[9]	Mont M A, Beaver W B, Dysart S H, et al. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results?of a randomized controlled trial [J]. J Arthroplasty, 2018, 33(1): 90-96.
[10]	Dysart S H, Barrington J W, Gaizo D J, et al. Local infiltration analgesia with liposomal bupivacaine improves early outcomes after total knee arthroplasty: 24-hour data from the PILLAR study [J]. J Arthroplasty, 2019, 34(5): 882-886.e1.
[11]	Dysart S, Snyder M A, Mont M A. A randomized, multicenter, double-blind study of local infiltration analgesia with liposomal bupivacaine for postsurgical pain following total knee arthroplasty: rationale and design of the pillar trial [J]. Surg Technol Int, 2016, 30: 261-267.
[12]	Chughtai M, Cherian J J, Mistry J B, et al. Liposomal bupivacaine suspension can reduce lengths of stay and improve discharge status of patients undergoing total knee arthroplasty [J]. J Knee Surg, 2016, 29(3): 224-227.
[13]	Asche C V, Dagenais S, Kang A, et al. Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions [J]. J Med Econ, 2019, 22(1): 85-94.
[14]	Schoenherr J W, Gonzalez M, Serrano R, et al. Quality of recovery after rotator cuff repair with interscalene liposomal bupivacaine versus interscalene nerve catheter [J]. Orthop J Sports Med, 2022, 10(11): 23259671221134819.
[15]	Li Y, Shen Z, Wang H, et al. Efficacy of liposomal bupivacaine for pain control in shoulder surgery: a systematic review and meta-analysis [J]. J Shoulder Elbow Surg, 2022, 31(9): 1957-1968.
[16]	Hutchins J L, Kesha R, Blanco F, et al. Ultrasound-guided subcostal transversus abdominis plane blocks with liposomal bupivacaine vs. non-liposomal bupivacaine for postoperative pain control after laparoscopic hand-assisted donor nephrectomy: a prospective randomised observer-blinded study [J]. Anaesthesia, 2016, 71(8): 930-937.
[17]	Nedeljkovic S S, Ketta A, Vallejo M C, et al. Transversus abdominis plane block with liposomal bupivacaine for pain after cesarean delivery in a multicenter, randomized, double-blind, controlled trial [J]. Anesth Analg, 2020, 131(6): 1830-1839.
[18]	Alexander J C, Sunna M, Goldenmerry Y, et al. Comparison of transversus abdominis plane blocks with liposomal bupivacaine versus ropivacaine in open total abdominal hysterectomy [J]. Proc (Bayl Univ Med Cent), 2022, 35(6): 746-750.
[19]	Truong A, Fleshner P R, Mirocha J M, et al. A prospective randomized trial of surgeon-administered intraoperative transversus abdominis plane block with bupivacaine against liposomal bupivacaine: the tingle trial [J]. Dis Colon Rectum, 2021, 64(7): 888-898.
[20]	Turan A, Cohen B, Elsharkawy H, et al. Transversus abdominis plane block with liposomal bupivacaine versus continuous epidural analgesia for major abdominal surgery: the EXPLANE randomized trial [J]. J Clin Anesth, 2022, 77: 110640.
[21]	Felling D R, Jackson M W, Ferraro J, et al. Liposomal bupivacaine transversus abdominis plane block versus epidural analgesia in a colon and rectal surgery enhanced recovery pathway: a randomized clinical trial [J]. Dis Colon Rectum, 2018, 61(10): 1196-1204.
[22]	Torgeson M, Kileny J, Pfeifer C, et al. Conventional epidural vs transversus abdominis plane block with liposomal bupivacaine: a randomized trial in colorectal surgery [J]. J Am Coll Surg, 2018, 227(1): 78-83.
[23]	Forero M, Adhikary S D, Lopez H, et al. The erector spinae plane block: a novel analgesic technique in thoracic neuropathic pain [J]. Reg Anesth Pain Med, 2016, 41(5): 621-627.
[24]	Tirotta C F, Armendi A J, Horn N D, et al. A multicenter study to evaluate the pharmacokinetics and safety of liposomal bupivacaine for postsurgical analgesia in pediatric patients aged 6 to less than 17 years (PLAY) [J]. J Clin Anesth, 2021, 75: 110503.
[25]	Stondell C, Roberto R. Erector spinae plane blocks with liposomal bupivacaine for pediatric scoliosis surgery [J]. J Am Acad Orthop Surg Glob Res Rev, 2022, 6(1):21-26.
[26]	Hubler C P, Bevil K M, Greiner J J, et al. Liposomal bupivacaine versus standard bupivacaine in the adductor canal for total knee arthroplasty: a randomized, controlled trial [J]. Orthopedics, 2021, 44(4): 249-255.
[27]	Malige A, Pellegrino A N, Kunkle K, et al. Liposomal bupivacaine in adductor canal blocks before total knee arthroplasty leads to improved postoperative outcomes: a?randomized controlled trial [J]. J Arthroplasty, 2022, 37(8): 1549-1556.
[28]	Viscusi E R, Candiotti K A, Onel E, et al. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers [J]. Reg Anesth Pain Med, 2012, 37(6): 616-622.
[29]	Boogaerts J, Declercq A, Lafont N, et al. Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions [J]. Anesth Analg, 1993, 76(3): 553-555.
[30]	Grant G J, Vermeulen K, Langerman L, et al. Prolonged analgesia with liposomal bupivacaine in a mouse model [J]. Reg Anesth, 1994, 19(4): 264-269.
[31]	Davidson E M, Barenholz Y, Cohen R, et al. High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans [J]. Anesth Analg, 2010, 110(4): 1018-1023.
[32]	Cheung B M, Ng P Y, Liu Y, et al. Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: a phase 1 study [J]. BMC Anesthesiol, 2021, 21(1): 197-204.
[33]	徐建国,邓小明,冯艺,等. 成人手术后疼痛处理专家共识[J]. 临床麻醉学杂志,2019,33(9):911-917.
[34]	Cohen B, Glosser L, Saab R, et al. Incidence of adverse events attributable to bupivacaine liposome injectable suspension or plain bupivacaine for postoperative pain in pediatric surgical patients: a retrospective matched cohort analysis [J]. Paediatr Anaesth, 2019, 29(2): 169-174.
[35]	Baxter R, Bramlett K, Onel E, et al. Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective, controlled clinical studies [J]. Clin Ther, 2013, 35(3): 312-320.
[36]	Richard B M, Rickert D E, Newton P E, et al. Safety evaluation of EXPAREL (depofoam bupivacaine) administered by repeated subcutaneous injection in rabbits and dogs: species comparison [J]. J Drug Deliv, 2011, 2011: 467429.
[37]	Malige A,Yeazell S, Ng-Pellegrino A, et al. Risk factors for complications and return to the emergency department after interscalene block using liposomal bupivacaine for shoulder surgery [J]. J Shoulder Elbow Surg, 2020, 29(11): 2332-2338.
[38]	Buys M J, Murphy M F, Warrick C M, et al. Serum bupivacaine concentration after periarticular injection with a mixture of liposomal bupivacaine and bupivacaine hcl during total knee arthroplasty [J]. Reg Anesth Pain Med, 2017, 42(5): 582-587.